For example, in Alzheimer’s disease (AD), activated AEP cleaves endogenous tau protein in the ageing brain, allowing tau fragments to form insoluble fibrils that are neurotoxic and lead to symptoms of AD (19). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.